# Curon Biopharmaceutical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/curon-biopharmaceutical

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.curonbiopharma.com
- Total disclosed funding: $150M
- Latest round: Series A (Jul 30, 2018)
- Investors on record: 3

## About

Based in China, Curon Biopharmaceutical operates as a developer of novel cancer immuno-therapeutic agents.

## Funding rounds

- Series A, Jul 30, 2018, $150M — Temasek Holdings, Boyu Capital, 6 Dimensions Capital

## Investors

- Temasek Holdings — Series A
- Boyu Capital (https://capitalatlas.ai/funds/boyu-capital) — Series A
- 6 Dimensions Capital (https://capitalatlas.ai/funds/6-dimensions-capital) — Series A